Where Serum Amyloid A (SAA) is reported
Also listed as: Acute phase protein
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Long COVID | ↑ elevated | healthy controls | Systemic inflammation | Baalbaki et al. 2025 |
Frequently asked questions
In which conditions is Serum Amyloid A (SAA) altered?
In the OSMF atlas Serum Amyloid A (SAA) is reported in Long COVID. It is elevated in 1 across 1 entries.
What is the LOINC code for Serum Amyloid A (SAA)?
Entries in this atlas use LOINC 35648-5. LOINC codes identify the laboratory observation so results can be compared across systems.
Is one abnormal Serum Amyloid A (SAA) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Open Source Medicine Foundation. (2026). Serum Amyloid A (SAA) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/serum-amyloid-a-saa.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.